Epworth HealthCare is going live with the Velos Research system infrastructure for the management of its clinical trials, ethics and governance of all research conducted across the organisation.
The technology platform provides enhanced visibility on compliance and patient safety while reducing the administrative burdens associated with clinical trials.
International research institutions currently utilising the platform include The Mayo Clinic, Columbia University, Duke University, and National Cancer Center in South Korea.
Epworth HealthCare became the first institution in Australia to apply the Velos System to all aspects of their research program.
Epworth group manager of finance and operations, Alan Taylor, said Epworth HealthCare is committed to promoting research that translates directly to improvements in healthcare.
“Epworth saw value in having an end-to-end digital approach to both approving ethics for research and managing the research as it reduced duplication and manual handling and also provided us with a systematised ‘one stop shop’ for research.
“Epworth HealthCare first rolled out the Study Management and Patient Management components of Velos eResearch CTMS, Velos' research system in 2014. Since then, our experts in Ethics and Governance worked with Velos engineers to create a 'tailored-fit' for ethics review and research management from an Australian perspective.
“This bespoke system began its rollout earlier this year, and now all Research Ethics and Governance at Epworth HealthCare will be managed using Velos.
“We have made a significant investment in digital automation of our research processes, to ensure regulatory compliance and to increase efficiency for patients and clinicians.
“Velos has been an excellent partner and has worked closely with us to develop a system suitable for the Australian clinical research environment. We believe that the Velos Research system deployed at Epworth Richmond is the first end-to-end electronic research management system in Australia with the Ethics and Governance platform on the front end and the Clinical Trials Management system at the back end connected by an automated flow of data,” added Mr Taylor.
Suresh Kumar, general manager of Velos Australia, said the compamy is excited about the success of the rollout.
“The rollout in any institution is acutely dependent upon the quality of the management and the involvement and interest we get from leaders in the institution. On all these scores, Velos is delighted to find a partner in Epworth that is using Velos software in Australia to fully deliver on promises to the clinical research community."